Gene · 54915
Papers3,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL3 facilitates the malignant progression of prostate cancer by inhibiting GDF15-mediated ferroptosis via a YTHDF1-dependent m6A mechanism. | Pathol Res Pract | 2026 | 41687474 | PubTator, text mining | PubMed |
| Proteomic dynamics of bull sperm during post-testicular maturation. | BMC Genomics | 2026 | 41680611 | PubTator, text mining | PubMed |
| METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers. | Nat Cancer | 2026 | 41652220 | PubTator, text mining | PubMed |
| N6-methyladenosine RNA methylation regulators and their target SOX2 as circulating biomarkers of colorectal cancer: Insights towards early diagnosis and staging. | Comput Biol Med | 2026 | 41621400 | PubTator, text mining | PubMed |
| Redox-sensitive N6-methyladenosine RNA epitranscriptomic mechanisms in environmental stress and hazard. | Redox Biol | 2026 | 41616571 | PubTator, text mining | PubMed |
| The role of m6A RNA methyltransferase METTL3 in drug resistance mechanisms in acute myeloid leukemia. | Blood Res | 2026 | 41615563 | PubTator, text mining | PubMed |
| COL23A1 promotes tumor progression and glycolytic reprogramming in endometrial cancer via METTL14-m6A-YTHDF1 axis. | Cytotechnology | 2026 | 41613302 | PubTator, text mining | PubMed |
| The role of HMGA1 in genome stability: Implications in human cancer. | Cell Mol Life Sci | 2026 | 41586900 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Meta-unstable mRNAs in activated CD8+ T cells are defined by interlinked AU-rich elements and m6A mRNA methylation. | Nat Commun | 2026 | 41571642 | PubTator, text mining | PubMed |
| Time Is of the Essence: Temporal Dynamics of Epigenetic Landscapes as Therapeutic Targets in Traumatic Brain Injury. | ACS Chem Neurosci | 2026 | 41565603 | PubTator, text mining | PubMed |
| RUNX1 N6-methyladenosine methylation enhances cytoskeleton remodelling and boosts cardiac fibrosis. | Cardiovasc Res | 2026 | 41555207 | PubTator, text mining | PubMed |
| Methionine restriction for cancer therapy: From preclinical studies to clinical trials. | Cancer Pathog Ther | 2026 | 41550357 | PubTator, text mining | PubMed |
| METTL14-mediated RNA m6A modifications of TET1 and TET2 in duck myoblast differentiation. | Poult Sci | 2026 | 41547168 | PubTator, text mining | PubMed |
| YTHDF1 Drives Ferroptosis in Ulcerative Colitis via m6A-ACSL4 Stabilization. | APMIS | 2026 | 41537222 | PubTator, text mining | PubMed |
| The role of N6-methyladenosine associated genes in ischemic stroke risk: interplay with environmental factors. | J Thromb Thrombolysis | 2026 | 41466169 | PubTator, text mining | PubMed |
| WTAP contributes to the malignancy and stemness of hepatocellular carcinoma through upregulating N6-methyladenosine modification of ITGB4. | Pathol Res Pract | 2026 | 41456451 | PubTator, text mining | PubMed |
| Correlation of bioinformatics-based m6A methylation regulators with prognosis in oral squamous cell carcinoma patients. | J Craniomaxillofac Surg | 2026 | 41455610 | PubTator, text mining | PubMed |
| m6A modification in the 3'‑leader region of EBOV genome antagonizes ISG20 to facilitate viral replication. | Int J Biol Macromol | 2026 | 41423124 | PubTator, text mining | PubMed |
| Jianpi Jiedu formula modulates glutamine metabolism to inhibit colorectal cancer liver metastasis. | Phytomedicine | 2026 | 41385945 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54915/papers?page=5